yPURPOSE: To report anterior uveitis as a late side-effect of topical brimo
nidine tartrate 0.2% (Alphagan; Allergan Inc., Irvine, California).
METHODS: Four patients aged 79 to 91 (mean, 83) years, who developed acute
anterior uveitis while using topical brimonidine for chronic glaucoma, were
clinically evaluated for causes of uveitis, When the inflammation had comp
letely cleared, topical brimonidine was recommenced in one eye only to dete
rmine causality,
RESULTS: All four patients developed acute granulomatous anterior uveitis,
which resolved rapidly on stopping brimonidine and receiving treatment with
topical corticosteroids. The uveitis occurred 11 to 15 (mean, 13.8) months
after commencement of brimonidine 0.2% twice daily. None of the patients h
ad a previous history of uveitis, and no other identifiable cause of uveiti
s was found. In all patients, on rechallenge with brimonidine instilled twi
ce daily to one eye, uveitis recurred within 3 weeks in that eye only,
CONCLUSIONS: These findings suggest that brimonidine can cause anterior uve
itis as a late side effect, The inflammation settles rapidly on stopping th
e medication and on using topical corticosteroids and recurs on rechallenge
with brimonidine. (C) 2000 by Elsevier Science Inc, All rights reserved.